Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added 2026-04-01 and 2027-02-25; removed 2027-02-18 and 2026-02-19 from the Study Record Dates section.
    Difference
    0.1%
    Check dated 2026-04-02T00:21:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-25T20:38:33.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added the disease tag 'Malignant pleural mesothelioma' and included the Genetic and Rare Diseases Information Center as a resource; several older update dates were removed.
    Difference
    0.3%
    Check dated 2026-03-18T15:01:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. There are no user-visible changes to the study details or layout.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:16.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added site revision note Revision: v3.4.2. Removed the government funding lapse notice and the previous Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T09:18:19.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    - Added a site-wide notice about a lapse in government funding and updated operating status. - Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:17:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.